CSF2 and myeloid sarcoma: For therapeutic approaches and interpretation of murine disease models, particularly for MS, it will be highly relevant to further understand the differences in the differentiation requirements of murine and human IL-17+ and GM-CSF+ CD4+ T cells in the future.